Session » (2387–2424) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III
-
Abstract Number: 2387
Large Vessel Involvement and the Risk of Severe Infections in Patients with Giant Cell Arteritis – a Population-based Study
-
Abstract Number: 2388
Increased Risk of Severe Infections in Early Giant Cell Arteritis: A Population- based Study
-
Abstract Number: 2390
Characterization of Senescent Cells in Temporal Arteries of Patients with Giant Cell Arteritis Reveal an Inflammatory Phenotype and Strong Dependence from IL-6
-
Abstract Number: 2391
Epidemiology and Predictors of Relapse in Giant Cell Arteritis: Results of the ARTESER Register
-
Abstract Number: 2392
Characterization of Arterial Dendritic Cells in Polymyalgia Rheumatica and Giant Cell Arteritis
-
Abstract Number: 2393
CXCL9/IL-6 and MMP3/CD141 Ratio Allow to Discriminate Between Isolated PMR and GCA/PMR Overlap
-
Abstract Number: 2394
18f-FDG-PET/CT for Giant Cell Arteritis Detection of Large Vessel Vasculitis: What Should We Take into Consideration? Analytical Study of the Arteser Registry
-
Abstract Number: 2395
Recommendations for Early Referral of Patients with Suspected Polymyalgia Rheumatica: An Initiative from the International Giant Cell Arteritis and Polymyalgia Rheumatica Study Group
-
Abstract Number: 2396
Diagnostic Performance of a Newly-Launched Canadian Fast-Track Ultrasound Clinic Performed by Rheumatologists for Diagnosis of Giant Cell Arteritis
-
Abstract Number: 2397
Impact of Exposure to Environmental Air Pollution on the Onset of Giant Cell Arteritis
-
Abstract Number: 2398
FDG Uptake in Limb Arteries at Diagnosis of Giant Cell Arteritis and Risk of Relapse: An Observational Cohort Study
-
Abstract Number: 2399
Ultrasound Is Comparable to Computed Tomography Angiography in Identifying Aortic Aneurysms in Patients with Giant Cell Arteritis
-
Abstract Number: 2400
Applanation Tonometry of the Temporal Arteries in Participants with Suspected Giant Cell Arteritis: A Proof of Concept
-
Abstract Number: 2401
A Study Defining the Optimal Sonographic Parameters for Intima-Media Thickness in Diagnosing Giant Cell Arteritis
-
Abstract Number: 2402
A Retrospective Analysis of Prevalence of Positive Temporal Artery Biopsies in African American Patients with Giant Cell Arteritis (GCA) in a Large Academic Health Center
-
Abstract Number: 2403
Systole and Diastole Ultrasound Wall Thickness Shows Significant Differences That Affect the Diagnosis and Assessment of Giant Cell Arteritis
-
Abstract Number: 2404
Subclinical Giant Cell Arteritis in Polimialgia Rheumatica: A Biomarker of High Relapse Risk
-
Abstract Number: 2405
Role of Mitochondria in Activation of Platelets in Giant Cell Arteritis
-
Abstract Number: 2406
Risk of Large Vessel Complications in Patients with Giant Cell Arteritis, a Population-based Study
-
Abstract Number: 2407
Immuno-permissive Antigen-presenting Cells in Giant Cell Arteritis
-
Abstract Number: 2408
The Use of the Southend GCA Probability Score (GCAPS) in Assessing the Risk of Giant Cell Arteritis in Australian Ophthalmological and General Medical Hospital Cohorts
-
Abstract Number: 2409
Concordance of Relapse Symptoms with Initial Baseline Presentation Features Among Patients with Giant Cell Arteritis
-
Abstract Number: 2410
Tocilizumab versus Methotrexate in Giant Cell Arteritis: A Retrospective Study to Compare Efficacy and Rapidity of These Steroid-sparing Agents in GCA Patients
-
Abstract Number: 2411
C-X-C Motif Chemokine Receptor 4-targeted Molecular Imaging in Giant Cell Arteritis – a Head-to-head Comparison with FDG PET
-
Abstract Number: 2412
Evaluation of the Pretest Probability Score, Ultrasound and Biopsy on GCA Diagnose: Data from Real Clinical Practice
-
Abstract Number: 2413
Janus Kinase Inhibitors in Giant Cell Arteritis in Clinical Practice. Real-World Clinical Practice Study and Literature Review
-
Abstract Number: 2414
Relapse in Giant Cell Arteritis Treated with Tocilizumab. Predictive Factors
-
Abstract Number: 2415
Giant Cell Arteritis Is Associated with Worse Hospital Outcomes in Aortic Aneurysm/Dissection Hospitalizations: A Nationwide United States Population-Based Study
-
Abstract Number: 2416
Comparison of Clinical, Laboratory and Imaging Features of Relapses Between Takayasu and LV-GCA Patients. an Italian Monocentric Study
-
Abstract Number: 2417
Influence of Histological Tempol Artery Biopsy Findings on Outcomes of Biopsy-proven Giant Cell Arteritis in Italian Patients : A Long Single Center Follow-up Study
-
Abstract Number: 2418
Effectiveness of Dose Spacing with Tocilizumab in Giant Cell Arteritis Treatment
-
Abstract Number: 2419
Visual Manifestations in Giant Cell Arteritis: Identification of Risk Factors from the ARTESER Registry
-
Abstract Number: 2420
Sex Differences in Giant Cell Arteritis: Data from the ARTESER Registry
-
Abstract Number: 2421
Optic Nerve Sheath Measurement on Ultrasound: A Novel Diagnostic Test for Giant Cell Arteritis
-
Abstract Number: 2422
Magnetic Resonance Imaging Reflects Disease Activity in the “Giant Cell Arteritis Treatment with Ultra-short Glucocorticoids and Tocilizumab” Trial (The GUSTO Trial)